{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T04:22:14Z","timestamp":1776399734866,"version":"3.51.2"},"reference-count":67,"publisher":"Universa BV","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AGEB"],"published-print":{"date-parts":[[2021,6]]},"abstract":"<jats:p>Portal vein thrombosis (PVT) is a splanchnic vascular disorder characterised by a recent or chronic thrombotic occlusion of the portal venous system. Its aetiology is miscellaneous, and its management is demanding since PVT can play a critical role as far as morbidity and mortality are concerned. Indeed, PVT can develop as a complication of portal hypertension (PH), in association or not with advanced chronic liver disease, and aggravate its clinical consequences such as variceal bleeding and ascites. Furthermore, a diagnosis of PVT in a non-cirrhotic context can potentially reveal a previously unknown hypercoagulable condition, requiring further diagnostic steps and specific treatment in addition to anticoagulation. In addition to established therapeutic approaches, new strategies, including newer pharmacological treatments and interdisciplinary invasive procedures, gain more attention and have been increasingly introduced into clinical practice. This review aims at discussing the current knowledge in terms of treatment options for PVT.<\/jats:p>","DOI":"10.51821\/84.2.327","type":"journal-article","created":{"date-parts":[[2021,7,30]],"date-time":"2021-07-30T00:01:45Z","timestamp":1627603305000},"page":"327-332","source":"Crossref","is-referenced-by-count":25,"title":["Portal vein thrombosis: an overview of current treatment options"],"prefix":"10.51821","volume":"84","author":[{"given":"A","family":"Galante","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"De Gottardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"27062","published-online":{"date-parts":[[2021,6]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"NORTHUP PG, GARCIA-PAGAN JC, GARCIA-TSAO G, INTAGLIATA NM, SUPERINA RA, ROBERTS LN, et al. Vascular Liver Disorders, Portal Vein Thrombosis, and Procedural Bleeding in Patients With Liver Disease : 2020 Practice Guidance by the American Association for the Study of Liver Diseases. : 130.","DOI":"10.1002\/hep.31646"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"INTAGLIATA NM, CALDWELL SH, TRIPODI A. Diagnosis, Development, and  Treatment  of  Portal  Vein  Thrombosis  in  Patients  With  and  Without  Cirrhosis. Gastroenterology. 2019, 156(6) : 1582-1599.e1.","DOI":"10.1053\/j.gastro.2019.01.265"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"BOSCH J, NAVASA M, GARCIA-PAG\u00c1N JC, DELACY AM, ROD\u00c9S J. Portal hypertension. Med. Clin. North Am. 1989 Jul, 73(4) : 931-53.","DOI":"10.1016\/s0025-7125(16)30646-0"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"SARIN SK, PHILIPS CA, KAMATH PS, CHOUDHURY A, MARUYAMA H, NERY FG, et  al. Toward a Comprehensive New Classification of Portal Vein  Thrombosis  in  Patients  With  Cirrhosis.  Gastroenterology.  2016  Oct,  151(4) : 574-577.e3.","DOI":"10.1053\/j.gastro.2016.08.033"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"FACCIA M, AINORA ME, PONZIANI FR, RICCARDI L, GARCOVICH M, GASBARRINI A, et al. Portal vein thrombosis in cirrhosis : Why a well-known  complication  is  still  matter  of  debate.  World  J.  Gastroenterol.  2019 Aug 21, 25(31) : 4437-51.","DOI":"10.3748\/wjg.v25.i31.4437"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"AMITRANO  L,  GUARDASCIONE  MA,  BRANCACCIO  V, MARGAGLIONE M, MANGUSO F, IANNACCONE L, et al. Risk factors and  clinical  presentation  of  portal  vein  thrombosis  in  patients  with  liver  cirrhosis. J. Hepatol. 2004 May, 40(5) : 736-41.","DOI":"10.1016\/j.jhep.2004.01.001"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"FRANCOZ C, BELGHITI J, VILGRAIN V, SOMMACALE D, PARADIS V,  CONDAT  B,  et  al.  Splanchnic  vein  thrombosis  in  candidates  for  liver  transplantation : usefulness of screening and anticoagulation. Gut. 2005 May, 54(5) : 691-7.","DOI":"10.1136\/gut.2004.042796"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"OGREN  M,  BERGQVIST  D,  BJ\u00d6RCK  M, ACOSTA  S,  ERIKSSON  H, STERNBY NH. Portal vein thrombosis : prevalence, patient characteristics and lifetime risk : a population study based on 23,796 consecutive autopsies. World J. Gastroenterol. 2006 Apr 7, 12(13) : 2115-9.","DOI":"10.3748\/wjg.v12.i13.2115"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"NERY F, CHEVRET S, CONDAT B, DE RAUCOURT E, BOUDAOUD L, RAUTOU P-E, et al. Causes and consequences of portal vein thrombosis in 1,243 patients with cirrhosis : results of a longitudinal study. Hepatol. Baltim. Md. 2015 Feb, 61(2) : 660-7.","DOI":"10.1002\/hep.27546"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"M\u00c4HRINGER-KUNZ A, STEINLE V, D\u00dcBER C, WEINMANN A, KOCH S, SCHMIDTMANN I, et  al.  Extent  of  portal  vein  tumour  thrombosis  in  patients with hepatocellular carcinoma : The more, the worse? Liver Int. Off. J. Int. Assoc. Study Liver. 2019, 39(2) : 324-31.","DOI":"10.1111\/liv.13988"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"CIAVARELLA A, GNOCCHI D, CUSTODERO C, LENATO GM, FIORE G, SABB\u00c0 C, MAZZOCCA A. Translational insight into prothrombotic state and hypercoagulation in nonalcoholic fatty liver disease. Thromb. Res. 2021 Feb, 198 : 139-150.","DOI":"10.1016\/j.thromres.2020.12.002"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"VILLA  E,  CAMM\u00c0  C,  MARIETTA  M,  LUONGO  M,  CRITELLI  R, COLOPI  S,  et  al.  Enoxaparin  prevents  portal  vein  thrombosis  and  liver  decompensation in patients with advanced cirrhosis. Gastroenterology. 2012 Nov, 143(5) : 1253-1260.e4.","DOI":"10.1053\/j.gastro.2012.07.018"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"PLESSIER  A,  DARWISH-MURAD  S,  HERNANDEZ-GUERRA  M, CONSIGNY Y, FABRIS F, TREBICKA J, et al. Acute portal vein thrombosis unrelated  to  cirrhosis  :  a  prospective  multicenter  follow-up  study.  Hepatol. Baltim. Md. 2010 Jan, 51(1) : 210-8.","DOI":"10.1002\/hep.23259"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"COREMANS L, STRUBBE B, PEETERS H. Venous thromboembolism in patients with inflammatory bowel disease : review of literature and practical algorithms. Acta Gastroenterol. Belg. 2021 Jan-Mar, 84(1) : 79-85.","DOI":"10.51821\/84.1.910"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"NORONHA  FERREIRA  C,  SEIJO  S,  PLESSIER  A,  SILVA-JUNIOR G,  TURON  F,  RAUTOU  P-E,  et  al.  Natural  history  and  management  of esophagogastric  varices  in  chronic  noncirrhotic,  nontumoral  portal  vein  thrombosis. Hepatol. Baltim. Md. 2016 May, 63(5) : 1640-50.","DOI":"10.1002\/hep.28466"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"SPAANDER  MCW,  HOEKSTRA  J,  HANSEN  BE,  VAN  BUUREN  HR, LEEBEEK FWG, JANSSEN HLA. Anticoagulant therapy in patients with non-cirrhotic  portal  vein  thrombosis  :  effect  on  new  thrombotic  events  and  gastrointestinal bleeding. J. Thromb. Haemost. JTH. 2013 Mar, 11(3) : 452-9.","DOI":"10.1111\/jth.12121"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"AMITRANO  L,  GUARDASCIONE  MA,  SCAGLIONE  M,  PEZZULLO L,  SANGIULIANO  N,  ARMELLINO  MF,  et  al.  Prognostic  factors  in  noncirrhotic patients with splanchnic vein thromboses. Am. J. Gastroenterol. 2007 Nov, 102(11) : 2464-70.","DOI":"10.1111\/j.1572-0241.2007.01477.x"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"ORR  DW,  HARRISON  PM,  DEVLIN  J,  KARANI  JB,  KANE  PA, HEATON ND, et al. Chronic mesenteric venous thrombosis : evaluation and determinants  of  survival  during  long-term  follow-up.  Clin.  Gastroenterol.  Hepatol. Off. Clin. Pract. J. Am. Gastroenterol. Assoc. 2007 Jan, 5(1) : 80-6.","DOI":"10.1016\/j.cgh.2006.09.030"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"HERN\u00c1NDEZ-GEA V, DE GOTTARDI A, LEEBEEK FWG, RAUTOU P-E, SALEM R, GARCIA-PAGAN JC. Current  knowledge  in  pathophysiology  and  management  of  Budd-Chiari  syndrome  and  non-cirrhotic  non-tumoral  splanchnic vein thrombosis. J. Hepatol. 2019 Jul, 71(1) : 175-99.","DOI":"10.1016\/j.jhep.2019.02.015"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"LISMAN  T,  PORTE  RJ.  Pathogenesis,  prevention,  and  management  of bleeding and thrombosis in patients with liver diseases. Res. Pract. Thromb. Haemost. 2017 Oct, 1(2) : 150-61.","DOI":"10.1002\/rth2.12028"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"QI X, GUO X, YOSHIDA EM, M\u00c9NDEZ-S\u00c1NCHEZ N, DE STEFANO V, TACKE F, et al. Transient portal vein thrombosis in liver cirrhosis. BMC Med. 2018 Jun 5, 16(1) : 83.","DOI":"10.1186\/s12916-018-1069-8"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"TREBICKA  J,  STRASSBURG  CP.  Etiology  and  Complications  of  Portal  Vein Thrombosis. Viszeralmedizin. 2014 Dec, 30(6) : 375-80.","DOI":"10.1159\/000369987"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"LA MURA V, BRAHAM S, TOSETTI G, BRANCHI F, BITTO N, MOIA M, et al. Harmful and Beneficial Effects of Anticoagulants in Patients With Cirrhosis  and  Portal  Vein  Thrombosis.  Clin.  Gastroenterol.  Hepatol.  Off.  Clin. Pract. J. Am. Gastroenterol. Assoc. 2018, 16(7) : 1146-1152.e4.","DOI":"10.1016\/j.cgh.2017.10.016"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"HIBI T, NISHIDA S, LEVI DM, SELVAGGI G, TEKIN A, FAN J, et  al.  When  and  why  portal  vein  thrombosis  matters  in  liver  transplantation  :  a  critical audit of 174 cases. Ann. Surg. 2014 Apr, 259(4) : 760-6.","DOI":"10.1097\/sla.0000000000000252"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"CONZEN KD, POMFRET EA. Liver transplant in patients with portal vein thrombosis : Medical and surgical requirements. Liver Transplant. Off. Publ. Am. Assoc. Study Liver Dis. Int. Liver Transplant. Soc. 2017, 23(S1) : S59-63.","DOI":"10.1002\/lt.24856"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"ENGLESBE  MJ,  KUBUS  J,  MUHAMMAD  W,  SONNENDAY  CJ, WELLING  T,  PUNCH  JD,  et  al.  Portal  vein  thrombosis  and  survival  in  patients  with  cirrhosis.  Liver  Transplant.  Off.  Publ. Am. Assoc.  Study  Liver  Dis. Int. Liver Transplant. Soc. 2010 Jan, 16(1) : 83-90.","DOI":"10.1002\/lt.21941"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"ENGLESBE  MJ,  SCHAUBEL  DE,  CAI  S,  GUIDINGER  MK,  MERION RM.  Portal  vein  thrombosis  and  liver  transplant  survival  benefit.  Liver Transplant. Off. Publ. Am. Assoc. Study Liver Dis. Int. Liver Transplant. Soc. 2010 Aug, 16(8) : 999-1005.","DOI":"10.1002\/lt.22105"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"TURNES J, GARC\u00cdA-PAG\u00c1N JC, GONZ\u00c1LEZ M, ARACIL C, CALLEJA JL,  RIPOLL  C,  et  al.  Portal  hypertension-related  complications  after  acute  portal vein thrombosis : impact of early anticoagulation. Clin. Gastroenterol. Hepatol.  Off.  Clin.  Pract.  J.  Am.  Gastroenterol.  Assoc.  2008  Dec,  6(12) : 1412-7.","DOI":"10.1016\/j.cgh.2008.07.031"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"AMITRANO  L,  GUARDASCIONE  MA,  MENCHISE A,  MARTINO  R, SCAGLIONE M, GIOVINE S, et al. Safety and efficacy of anticoagulation therapy  with  low  molecular  weight  heparin  for  portal  vein  thrombosis  in  patients with liver cirrhosis. J. Clin. Gastroenterol. 2010 Jul, 44(6) : 448-51.","DOI":"10.1097\/mcg.0b013e3181b3ab44"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"LOFFREDO  L,  PASTORI  D,  FARCOMENI  A,  VIOLI  F.  Effects  of Anticoagulants  in  Patients  With  Cirrhosis  and  Portal  Vein  Thrombosis  :  A  Systematic Review and Meta-analysis. Gastroenterology. 2017, 153(2) : 480-487.e1.","DOI":"10.1053\/j.gastro.2017.04.042"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"NERY  F,  VALADARES  D,  MORAIS  S,  GOMES  MT,  DE  GOTTARDI A. Efficacy and Safety of Direct-Acting Oral Anticoagulants Use in Acute Portal Vein Thrombosis Unrelated to Cirrhosis. Gastroenterol. Res. 2017 Apr, 10(2) : 141-3.","DOI":"10.14740\/gr806w"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"AGNELLI  G,  BULLER  HR,  COHEN  A,  CURTO  M,  GALLUS  AS, JOHNSON M, et  al. Apixaban  for  extended  treatment  of  venous  thrombo-embolism. N. Engl. J. Med. 2013 Feb 21, 368(8) : 699-708.","DOI":"10.1056\/nejmoa1207541"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"JANCZAK DT, MIMIER MK, MCBANE RD, KAMATH PS, SIMMONS BS,  BOTT-KITSLAAR  DM,  et  al.  Rivaroxaban  and  Apixaban  for  Initial  Treatment  of Acute Venous Thromboembolism  of Atypical  Location.  Mayo Clin. Proc. 2018 Jan, 93(1) : 40-7.","DOI":"10.1016\/j.mayocp.2017.10.007"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"LI A, GARCIA DA, LYMAN GH, CARRIER M. Direct oral anticoagulant (DOAC)  versus  low-molecular-weight  heparin  (LMWH)  for  treatment  of  cancer associated thrombosis (CAT) : A systematic review and meta-analysis. Thromb. Res. 2019 Jan, 173 : 158-63.","DOI":"10.1016\/j.thromres.2018.02.144"},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"NAYMAGON L, TREMBLAY D, ZUBIZARRETA N, MOSHIER E, TROY K, SCHIANO T, et al. The efficacy and safety of direct oral anticoagulants in noncirrhotic portal vein thrombosis. Blood. Adv. 2020 25, 4(4) : 655-66.","DOI":"10.1182\/bloodadvances.2019001310"},{"key":"ref35","doi-asserted-by":"publisher","unstructured":"INTAGLIATA NM, HENRY ZH, MAITLAND H, SHAH NL, ARGO CK, NORTHUP PG, et al. Direct Oral Anticoagulants in Cirrhosis Patients Pose Similar  Risks  of  Bleeding  When  Compared  to  Traditional Anticoagulation.  Dig. Dis. Sci. 2016 Jun, 61(6) : 1721-7.","DOI":"10.1007\/s10620-015-4012-2"},{"key":"ref36","doi-asserted-by":"publisher","unstructured":"INTAGLIATA  NM,  MAITLAND  H,  PELLITIER  S,  CALDWELL  SH. Reversal  of  direct  oral  anticoagulants  for  liver  transplantation  in  cirrhosis  :  A step forward. Liver Transplant. Off. Publ. Am. Assoc. Study Liver Dis. Int. Liver Transplant. Soc. 2017 Mar, 23(3) : 396-7.","DOI":"10.1002\/lt.24708"},{"key":"ref37","doi-asserted-by":"publisher","unstructured":"HUM J, SHATZEL JJ, JOU JH, DELOUGHERY TG. The efficacy and safety of direct oral anticoagulants vs traditional anticoagulants in cirrhosis. Eur. J. Haematol. 2017 Apr, 98(4) : 393-7.","DOI":"10.1111\/ejh.12844"},{"key":"ref38","unstructured":"DE GOTTARDI A, TREBICKA J, KLINGER C, PLESSIER A, SEIJO S, TERZIROLI  B,  et al.  Antithrombotic treatment with direct-acting oral anticoagulants  in  patients  with  splanchnic  vein  thrombosis  and  cirrhosis.  Liver Int. Off. J. Int. Assoc. Study Liver. 2017 May, 37(5) : 694-9."},{"key":"ref39","doi-asserted-by":"publisher","unstructured":"NAGAOKI  Y, AIKATA  H,  DAIJYO  K,  TERAOKA  Y,  SHINOHARA  F, NAKAMURA Y, et al. Efficacy and safety of edoxaban for treatment of portal vein thrombosis following danaparoid sodium in patients with liver cirrhosis. Hepatol. Res. Off. J. Jpn. Soc. Hepatol. 2018 Jan, 48(1) : 51-8.","DOI":"10.1111\/hepr.12895"},{"key":"ref40","doi-asserted-by":"publisher","unstructured":"DE  GOTTARDI  A,  GARCIA-PAGAN  JC,  VALDIG  Investigators.  The anticoagulant efficacy of rivaroxaban may be attenuated in cirrhotic patients. Liver Int. 2017 Aug, 37(8) : 1252.","DOI":"10.1111\/liv.13420"},{"key":"ref41","doi-asserted-by":"publisher","unstructured":"CONDAT B, PESSIONE F, HILLAIRE S, DENNINGER MH, GUILLIN MC,  POLIQUIN  M,  et  al.  Current  outcome  of  portal  vein  thrombosis  in  adults :  risk  and  benefit  of  anticoagulant  therapy.  Gastroenterology.  2001  Feb, 120(2) : 490-7.","DOI":"10.1053\/gast.2001.21209"},{"key":"ref42","doi-asserted-by":"publisher","unstructured":"PRIYANKA  P,  KUPEC  JT,  KRAFFT  M,  SHAH  NA,  REYNOLDS  GJ. Newer Oral Anticoagulants in the Treatment of Acute Portal Vein Thrombosis in Patients with and without Cirrhosis. Int J Hepatol. 2018, 2018 : 8432781.","DOI":"10.1155\/2018\/8432781"},{"key":"ref43","doi-asserted-by":"publisher","unstructured":"O\u2019LEARY JG, GREENBERG CS, PATTON HM, CALDWELL SH. AGA Clinical Practice Update : Coagulation in Cirrhosis. Gastroenterology. 2019 Jul, 157(1) : 34-43.e1.","DOI":"10.1053\/j.gastro.2019.03.070"},{"key":"ref44","doi-asserted-by":"publisher","unstructured":"NORTHUP  P,  REUTEMANN  B.  Management  of  Coagulation  and  Anti-coagulation in Liver Transplantation Candidates. Liver Transplant. Off. Publ. Am.  Assoc.  Study  Liver  Dis.  Int.  Liver  Transplant.  Soc.  2018  Aug,  24(8) : 1119-32.","DOI":"10.1002\/lt.25198"},{"key":"ref45","doi-asserted-by":"publisher","unstructured":"DELGADO  MG,  SEIJO  S,  YEPES  I,  ACH\u00c9CAR  L,  CATALINA  MV, GARC\u00cdA-CRIADO A, et al. Efficacy and safety of anticoagulation on patients with cirrhosis and portal vein thrombosis. Clin. Gastroenterol. Hepatol. Off. Clin. Pract. J. Am. Gastroenterol. Assoc. 2012 Jul, 10(7) : 776-83.","DOI":"10.1016\/j.cgh.2012.01.012"},{"key":"ref46","doi-asserted-by":"crossref","unstructured":"BAUER  KA.  Pros  and  cons  of  new  oral  anticoagulants.  Hematol. Am.  Soc. Hematol. Educ. Program. 2013, 2013 : 464-70.","DOI":"10.1182\/asheducation-2013.1.464"},{"key":"ref47","doi-asserted-by":"publisher","unstructured":"SARTORI  MT,  PRANDONI  P.  How  to  effectively  manage  the  event  of bleeding  complications  when  using  anticoagulants.  Expert  Rev.  Hematol. 2016 Jan, 9(1) : 37-50.","DOI":"10.1586\/17474086.2016.1112733"},{"key":"ref48","doi-asserted-by":"crossref","unstructured":"LIP GYH, LANE DA. Matching the NOAC to the Patient : Remember the Modifiable Bleeding Risk Factors. J. Am. Coll. Cardiol. 2015 Dec 1, 66(21) : 2282-4.","DOI":"10.1016\/j.jacc.2015.07.086"},{"key":"ref49","doi-asserted-by":"publisher","unstructured":"LIP  GYH,  BANERJEE  A,  BORIANI  G,  CHIANG  CE,  FARGO  R, FREEDMAN  B,  et al.  Antithrombotic  Therapy for  Atrial Fibrillation : CHEST Guideline and Expert Panel Report. Chest. 2018 Nov, 154(5) : 1121-201.","DOI":"10.1016\/j.chest.2018.07.040"},{"key":"ref50","doi-asserted-by":"publisher","unstructured":"SAMUELSON BT, CUKER A. Measurement and reversal of the direct oral anticoagulants. Blood Rev. 2017 Jan, 31(1) : 77-84.","DOI":"10.1016\/j.blre.2016.08.006"},{"key":"ref51","doi-asserted-by":"publisher","unstructured":"INTAGLIATA  NM,  MAITLAND  H,  NORTHUP  PG,  CALDWELL  SH. Treating thrombosis in cirrhosis patients with new oral agents : ready or not? Hepatol. Baltim. Md. 2015 Feb, 61(2) : 738-9.","DOI":"10.1002\/hep.27225"},{"key":"ref52","doi-asserted-by":"publisher","unstructured":"SERPER  M,  WEINBERG  EM,  COHEN  JB,  REESE  PP,  TADDEI  TH, KAPLAN  DE.  Mortality  and  Hepatic  Decompensation  in  Patients  With  Cirrhosis and Atrial Fibrillation Treated With Anticoagulation. Hepatol. 2020 Apr, 73 : 219-232","DOI":"10.1002\/hep.31264"},{"key":"ref53","doi-asserted-by":"publisher","unstructured":"POTZE  W,  ARSHAD  F,  ADELMEIJER  J,  BLOKZIJL  H,  VAN  DEN BERG AP, MEIJERS JCM, et al. Differential in vitro inhibition of thrombin generation  by  anticoagulant  drugs  in  plasma  from  patients  with  cirrhosis. PloS One. 2014, 9(2) : e88390.","DOI":"10.1371\/journal.pone.0088390"},{"key":"ref54","doi-asserted-by":"publisher","unstructured":"POTZE W, ADELMEIJER J, LISMAN T. Decreased in vitro anticoagulant potency of Rivaroxaban and Apixaban in plasma from patients with cirrhosis. Hepatol. Baltim. Md. 2015 Apr, 61(4) : 1435-6.","DOI":"10.1002\/hep.27350"},{"key":"ref55","doi-asserted-by":"publisher","unstructured":"VALERIANI E, DI NISIO M, RIVA N, COHEN O, PORRECA E, SENZOLO M, et al. Anticoagulant Treatment for Splanchnic Vein Thrombosis in Liver Cirrhosis : A Systematic Review and Meta-Analysis. Thromb. Haemost. 2021 Feb 1 : 10.1055\/s-0040-1722192.","DOI":"10.1055\/s-0040-1722192"},{"key":"ref56","unstructured":"Multicenter  Prospective  Randomized  Trial  of  the  Effect  of  Rivaroxaban  on  Survival  and  Development  of  Complications  of  Portal  Hypertension  in  Patients With Cirrhosis : https: \/\/clinicaltrials.gov\/ct2\/show\/NCT02643212"},{"key":"ref57","doi-asserted-by":"publisher","unstructured":"THORNBURG  B,  DESAI  K,  HICKEY  R,  HOHLASTOS  E,  KULIK  L, GANGER D, et al. Pretransplantation Portal Vein Recanalization and Trans-jugular  Intrahepatic  Portosystemic  Shunt  Creation  for  Chronic  Portal  Vein  Thrombosis  :  Final Analysis  of  a  61-Patient  Cohort.  J.  Vasc.  Interv.  Radiol  JVIR. 2017 Dec, 28(12) : 1714-1721.e2.","DOI":"10.1016\/j.jvir.2017.08.005"},{"key":"ref58","doi-asserted-by":"publisher","unstructured":"SALEM R, VOUCHE M, BAKER T, HERRERO JI, CAICEDO JC, FRYER J,  et  al.  Pretransplant  Portal  Vein  Recanalization-Transjugular  Intrahepatic  Portosystemic  Shunt  in  Patients  With  Complete  Obliterative  Portal  Vein  Thrombosis. Transplantation. 2015 Nov, 99(11) : 2347-55.","DOI":"10.1097\/tp.0000000000000729"},{"key":"ref59","doi-asserted-by":"publisher","unstructured":"ROSENQVIST K, ERIKSSON L-G, RORSMAN F, SANGFELT P, NYMAN R.  Endovascular  treatment  of  acute  and  chronic  portal  vein  thrombosis  in  patients  with  cirrhotic  and  non-cirrhotic  liver.  Acta  Radiol.  Stockh.  Swed. 1987. 2016 May, 57(5) : 572-9.","DOI":"10.1177\/0284185115595060"},{"key":"ref60","doi-asserted-by":"publisher","unstructured":"CAO G, KO G-Y, SUNG K-B, YOON H-K, GWON DI, KIM J-H. Treatment of  postoperative  main  portal  vein  and  superior  mesenteric  vein  thrombosis  with balloon angioplasty and\/or stent placement. Acta Radiol. Stockh. Swed. 1987. 2013 Jun, 54(5) : 526-32.","DOI":"10.1177\/0284185113475917"},{"key":"ref61","doi-asserted-by":"publisher","unstructured":"SMALBERG  JH,  SPAANDER  MVMCW,  JIE  K-SG,  PATTYNAMA PMT, VAN BUUREN HR, VAN DEN BERG B, et  al. Risks and benefits of  transcatheter  thrombolytic  therapy  in  patients  with  splanchnic  venous  thrombosis. Thromb. Haemost. 2008 Dec, 100(6) : 1084-8.","DOI":"10.1160\/th08-01-0015"},{"key":"ref62","doi-asserted-by":"publisher","unstructured":"LIU  K,  LI  W-D,  DU  X-L,  LI  C-L,  LI  X-Q.  Comparison  of  Systemic  Thrombolysis  Versus  Indirect  Thrombolysis  via  the  Superior  Mesenteric  Artery in Patients with Acute Portal Vein Thrombosis. Ann. Vasc. Surg. 2017 Feb, 39 : 264-9.","DOI":"10.1016\/j.avsg.2016.06.029"},{"key":"ref63","doi-asserted-by":"publisher","unstructured":"WOLTER K, DECKER G, KUETTING D, TREBICKA J, MANEKELLER S, MEYER C, et al. Interventional Treatment of Acute Portal Vein Thrombosis. ROFO Fortschr. Geb. Rontgenstr. Nuklearmed. 2018, 190(8) : 740-6.","DOI":"10.1055\/a-0631-9265"},{"key":"ref64","doi-asserted-by":"publisher","unstructured":"RODRIGUES SG, SIXT S, ABRALDES JG, DE GOTTARDI A, KLINGER C,  BOSCH  J,  et  al.  Systematic  review  with  meta-analysis  :  portal  vein  recanalisation  and  transjugular  intrahepatic  portosystemic  shunt  for  portal  vein thrombosis. Aliment. Pharmacol. Ther. 2019, 49(1) : 20-30.","DOI":"10.1111\/apt.15044"},{"key":"ref65","doi-asserted-by":"publisher","unstructured":"THORNBURG  B,  DESAI  K,  HICKEY  R,  KULIK  L,  GANGER  D, BAKER  T,  et  al.  Portal  Vein  Recanalization  and  Transjugular  Intrahepatic  Portosystemic Shunt Creation for Chronic Portal Vein Thrombosis : Technical Considerations. Tech. Vasc. Interv. Radiol. 2016 Mar, 19(1) : 52-60.","DOI":"10.1053\/j.tvir.2016.01.006"},{"key":"ref66","doi-asserted-by":"publisher","unstructured":"VALENTIN  N,  KORRAPATI  P,  CONSTANTINO  J,  YOUNG A,  WEISBERG  I.  The  role  of  transjugular  intrahepatic  portosystemic  shunt  in  the  management  of  portal  vein  thrombosis  :  a  systematic  review  and  meta-analysis. Eur. J. Gastroenterol. Hepatol. 2018 Oct, 30(10) : 1187-93.","DOI":"10.1097\/meg.0000000000001219"}],"container-title":["Acta Gastro Enterologica Belgica"],"original-title":[],"language":"en","deposited":{"date-parts":[[2021,7,30]],"date-time":"2021-07-30T12:46:23Z","timestamp":1627649183000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ageb.be\/ageb-journal\/ageb-volume\/ageb-article\/1908\/Portal%20vein%20thrombosis:%20an%20overview%20of%20current%20treatment%20options\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":67,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,6]]},"published-print":{"date-parts":[[2021,6]]}},"URL":"https:\/\/doi.org\/10.51821\/84.2.327","relation":{},"ISSN":["1784-3227"],"issn-type":[{"value":"1784-3227","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]}}}